Cargando…
Selenium-Binding Protein 1 (SELENBP1) as Biomarker for Adverse Clinical Outcome After Traumatic Spinal Cord Injury
Introduction: Traumatic spinal cord injury (TSCI) presents a diagnostic challenge as it may have dramatic consequences for the affected patient. Additional biomarkers are needed for improved care and personalized therapy. Objective: Serum selenium binding protein 1 (SELENBP1) has been detected in my...
Autores principales: | Seelig, Julian, Heller, Raban Arved, Haubruck, Patrick, Sun, Qian, Klingenberg, Georg Jochen, Hackler, Julian, Crowell, Helena Lucia, Daniel, Volker, Moghaddam, Arash, Schomburg, Lutz, Biglari, Bahram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204909/ https://www.ncbi.nlm.nih.gov/pubmed/34140879 http://dx.doi.org/10.3389/fnins.2021.680240 |
Ejemplares similares
-
The Role of Magnesium in the Secondary Phase After Traumatic Spinal Cord Injury. A Prospective Clinical Observer Study
por: Sperl, André, et al.
Publicado: (2019) -
Zinc Concentration Dynamics Indicate Neurological Impairment Odds after Traumatic Spinal Cord Injury
por: Heller, Raban Arved, et al.
Publicado: (2020) -
Selenium Deficiency Is Associated with Mortality Risk from COVID-19
por: Moghaddam, Arash, et al.
Publicado: (2020) -
Pursuing More Aggressive Timelines in the Surgical Treatment of Traumatic Spinal Cord Injury (TSCI): A Retrospective Cohort Study with Subgroup Analysis
por: Bock, Tobias, et al.
Publicado: (2021) -
Serum Selenium Status as a Diagnostic Marker for the Prognosis of Liver Transplantation
por: Gül-Klein, Safak, et al.
Publicado: (2021)